Applications of 1-Ethyl-6-Fluoro-7-(4-Methylpiperazin-1-Yl)-4-Oxo-Quinoline-3-Carboxylic Acid in Industrial Manufacturing

1-Ethyl-6-Fluoro-7-(4-Methylpiperazin-1-Yl)-4-Oxo-Quinoline-3-Carboxylic Acid is a prominent fluoroquinolone intermediate used in multiple pharmaceutical and chemical synthesis processes. As the primary manufacturer, we deliver this raw material for downstream industries requiring high-purity standards, precise formulation ratios, and strict adherence to global compliance frameworks.

1. Pharmaceutical Active Pharmaceutical Ingredient (API) Synthesis

This raw material serves as a key intermediate in the manufacture of fluoroquinolone antibiotics, particularly ciprofloxacin and ofloxacin. It is introduced at the condensation stage where the carboxylic acid, ketone, and piperazinyl groups enable targeted modifications for API backbone assembly. Our customers require batch-to-batch consistency for cGMP validation and global regulatory submissions. Ingredient ratios are closely monitored, as minor deviations impact impurity profiles and final API quality.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP, EP, and JP monographs where applicable for fluoroquinolones
• FDA 21 CFR Part 210/211
• WHO Technical Report Series for antibiotics manufacturing

Typical usage ratio

• Used at stoichiometric ratios of 1:1 relative to the amine coupling partner; small excess (1.05-1.15 molar equivalents) may be required based on yield optimization studies

Downstream process integration

• Charged into the initial condensation and cyclization reactors, before hydrogenation and purification steps
• Monitored for critical related substances and residual solvents at every stage

Final product types

• Ciprofloxacin API
• Ofloxacin API
• Norfloxacin API
• Sparfloxacin API

2. Veterinary Bulk Drug Formulation

Veterinary drug manufacturers utilize this quinoline intermediate for large-volume, lower-cost synthesis of animal health APIs. Scale-up requires high-purity raw material to minimize downstream process contaminants. We supply for integration into continuous or batch production, where product flow and reaction times differ from human pharma. End use targets compliance with country-specific veterinary pharmacopeias and animal use residue standards.

Industry compliance standards

• Chinese Veterinary Pharmacopeia
• European Pharmacopoeia (EP 9.0, Veterinary Section)
• US FDA Green Book guidance for veterinary APIs
• CVM Guidance for Industry on antibiotic drug residues

Typical usage ratio

• Adjusted between 0.95–1.10 molar equivalents, with tighter control for residue management in edible tissues

Downstream process integration

• Loaded at initial coupling and deprotection steps before bulk crystallization or granulation

Final product types

• Enrofloxacin veterinary API
• Danofloxacin mesylate API
• Flumequine premix
• Veterinary injectable antibiotic powders

3. Chemical Reference Standards Production

Accredited laboratories and standards bodies use this material for chemical reference standards preparation. High-purity batches are sub-divided, verified against traceable analytical methods, and certified for qualitative and quantitative assay calibration. Trace impurities, water content, and stereochemistry confirmations are essential for lot release, and these attributes must match published compendial standards globally.

Industry compliance standards

• ISO/IEC 17025 for laboratory quality management systems
• USP Reference Standard documentation requirements
• EDQM Certification standards
• ISO Guide 34 for reference material producers

Typical usage ratio

• Used at 100% purity or diluted gravimetrically to certified concentrations for calibration solutions

Downstream process integration

• Introduced directly to weighing, characterization, and ampoule-filling stations
• HPLC and NMR testing confirm suitability before lot release

Final product types

• Primary and secondary chemical reference standards for fluoroquinolones
• Pharmacopoeial analytical standards
• Certified calibration kits for HPLC and GC analysis
• Reference tablets and solutions for routine QC laboratories

4. Specialty Fine Chemical Intermediates

Fine chemical producers use this molecule as a building block in synthesizing specialty heterocyclic systems. Advanced organic syntheses employ this compound for diversifying quinolones, creating precursors for dyes, advanced materials, and experimental pharmacophores. Custom synthesis routes require tight specification controls, tailored to individual project needs and downstream coupling agents.

Industry compliance standards

• ISO 9001-certified quality management systems
• REACH registration and compliance for EU chemicals
• Japan Chemical Substances Control Law (CSCL)
• Applicable CEFIC guidance for specialty chemicals

Typical usage ratio

• Typically 1:1 with respect to the next coupling partner; ratio adjusted (0.8–1.20 equivalents) according to yield, side-reaction suppression, or protection/deprotection cycle requirements

Downstream process integration

• Fed at early condensation or ring functionalization stages
• Sequential transformations based on target advanced intermediate or specialty heterocycle

Final product types

• Quinolone-based dyes and pigments
• Trial heterocyclic pharmacophores for pharmaceutical research
• Specialty intermediates for agrochemical R&D
• Building blocks for functionalized electronic materials